ACUMEN For All is investigating the effect of exercise, via telehealth, on quality of life and will help to determine if exercise has a positive effect on recovery following cancer treatment.

Research Objectives

Status

Completed

Recruitment

Closed

Patient Group

Women who have completed treatment for gynaecological cancer within the last five years

Total Participants

50

Study location

The University of Queensland, The Wesley Hospital Choices Cancer Support Centre, Dawn Complete Health and Wellbeing

Study type

Investigator Initiated

    Lead investigator    
            Dr Janine Porter-Steele        

About this research project

The ACUMEN trial aims to enhance the health-related quality of life and exercise self-efficacy for Australian women treated for gynecological cancer, particularly for patients in rural and remote areas. This study will assess the feasibility of a telehealth delivered exercise intervention for women with gynecological cancer. The cost and clinical effectiveness data from this feasibility trial and the proposed national telehealth trial will evidence that exercise mitigates the considerable personal and social costs of cancer treatment experienced by the target cohort. Armed with robust trial data and in partnership with peak cancer organisations, this trial may lead to an amendment to the Medicare Benefits Scheme to enable exercise physiology to become affordable and standard cancer recovery care.

Protocol Publication – https://journals.lww.com/acsm-tj/fulltext/2025/04180/telehealth_delivered_exercise_to_promote_health.17.aspx

Latest News

Queensland claims world-first Chair in Spatial Medicine

In a landmark move in diagnosing and treating chronic disease, Queensland has unveiled the world’s first Chair in Spatial Medicine – a prestigious, philanthropically-funded research leadership position appointed to Associate Professor Arutha Kulasinghe.

Gluten Threshold Study Findings

WRI researchers have made a groundbreaking discovery showing that even extremely small amounts of gluten can trigger measurable immune activation in people with treated coeliac disease – findings that could help refine international food labelling standards.

How Kira is Helping to Shape Global Coeliac Research

When Kira was invited to participate in the Gluten Threshold Study, led by Coeliac Disease & Immune Health Research Program Clinical Director Dr James Daveson, Kira didn’t hesitate. The study’s findings are expected to influence international food labelling standards – an outcome that gives Kira a genuine sense of purpose.

1 2 3 … 34 Next »